Nasdaq-listed Elicio Therapeutics has hired Megan Filoon as general counsel. In her new role, Filoon oversees corporate governance and...Read more
Nasdaq-listed Elicio Therapeutics has hired Megan Filoon as general counsel. In her new...Read more
Nasdaq
Nasdaq-listed Allogene Therapeutics has hired Earl Douglas as its new general counsel. Douglas was previously general counsel for...Read more
The 2023 proxy season was another hectic period for governance teams, but it also came with some welcome indicators for companies in...Read more
More than 45 percent of investor relations (IR) professionals globally say messaging in 2022 was the most pressing issue their company...Read more
Unlike other public companies, Nasdaq also serves as a market regulator and exchange operator. As such, its proxy statement is viewed...Read more
Earlier this month, governance, sustainability and IR professionals engaged in lively debates at the ESG Integration Forum , hosted by...Read more
‘We like to look for innovation within the proxy statement and we like to bring life to our proxy statement because we think that’s...Read more
Nasdaq has raised concerns about – and suggested changes to – the SEC’s plan to update the grounds on which companies may be allowed...Read more
Companies and their boards need to ensure their messaging is authentic as they shift – or consider moving toward – a stakeholder...Read more
The SEC’s planned modernization of beneficial ownership reporting requirements has sparked a variety of feedback, based at least in...Read more
